Astra Zeneca fick Swecares exportpris – ”Fenomenalt stark utveckling”

Ett globalt storbolag och en uppstickare delar på Swecare Export Awards 2024. Årets vinnare: läkemedelsjätten Astra Zeneca och sårvårdsbolaget PU sensor.

When carelessness, forgetfulness and coincidence become the researcher’s best friend

Forgetfulness, coincidence and a stroke of luck hardly make up a fruitful method of serious research. Or do they? Actually, a number of important medical advanc...

MSD discontinues development of cancer drugs after trial failures

MSD suspends Phase 3 trials for two drug programs for different forms of cancer after trial failures.

”De flesta stora läkemedelsbolagen tittar på radiofarmaka”

Intresset för radiofarmaka har blivit allt större och flera stora läkemedelsbolag satsar inom området. Framsteg inom fältet och den ökade kunskapen kring antikr...

Non-destructive testing and assembly control

Assess complete assembly.

Vaccine skeptic David Geier to lead study on link to autism

The American government is to launch a study on whether vaccines cause autism – and has appointed a well-known vaccine skeptic to lead the analysis.

She is CSL Behring's new Nordic General Manager

Since the beginning of january, Helena Bragd is the new Nordic General Manager for the biotech company CSL Behring and CEO of CSL Behring AB.

Anna Törner: Success requires bold decisions!

“Doing things right is fine, but doing the right things as soon as possible is even better”, writes Anna Törner in a column.

Moderna develops mRNA vaccine against norovirus

A highly anticipated vaccine is in late clinical evaluation and could be ready for approval within a couple of years. The target is the norovirus, often called ...

Nytt USA-godkännande för Astra Zenecas cancerläkemedel

Astra Zenecas storsäljande läkemedel Tagrisso i kombination med kemoterapi har godkänts i USA som behandling av vuxna patienter med lokalt avancerad eller metas...

LINK Medical recruits Swedish CEO

The Norwegian Contract Research Organization LINK Medical has recruited Anders Göransson as the new CEO.

Anna Törner: ”Orphan Designation – the "petite robe noire" of drug development”

It is easy to cling to various regulatory incentives, like orphan designation, and other expedited pathways, without understanding what they truly mean or wheth...

Astra Zeneca nådde inte mål i lungcancerstudie

Lucy Robertshaw: Artificial intelligence – is this really going to transform a patient’s life?

In a column Lucy Robertshaw reflects on how AI and new regulations will affect healthcare, innovation and the lives of future patients.

ZEISS continues to drive digital era forward in ophthalmology

2 million digitally planned cataract cases in the U.S. alone.

Collaboration in laboratory automation

The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a resu...

Astra Zeneca föll efter besvikelser i rapport

Läkemedelsjätten Astra Zeneca föll rejält på börsen på torsdagen efter ett något sämre resultat än väntat det fjärde kvartalet 2023. Samtidigt presenterar bolag...

Astra Zenecas Sverige-vd: ”Vi tror superstarkt på vår portfölj”

Det började med sommarjobb som operatör på Astras kemifabrik i Snäckviken. Över tre decennier och otaliga olika uppdrag senare är Södertäljesonen Per Alfredsson vd för hela Astra...

The new Astra Zeneca CEO: “An incredibly exciting phase”

Almost 27 years have passed since Per Alfredsson from Södertälje stepped into Astra Zeneca as a newly hired engineer. After countless different roles, including...

Joy at Egetis after positive CHMP opinion – ”The single most important milestone”

Stockholm-based Egetis Therapeutics has received a positive CHMP opinion for Emcitate, which could become the first approved treatment for the rare disease MCT8 deficiency."

Standardisation in automation

B. Braun Melsungen had a great idea and implemented it throughout the plant. Production for infusion solutions was to be largely standardised. B. Braun hoped th...

Toppnamn till Smartcellas styrelse

KI-professorn Anna Martling och Regina Fritsche-Danielson, vetenskaplig ledare för Astra Zenecas forskningsanläggning i Göteborg, tar bägge plats i biotech- och...

Anna Törner: Kalashnikovs in a new guise

Thanks to resisting European regulatory authorities, Europe has been spared the opioid epidemic. In the 1960s, the situation was the opposite as the American ph...

Lilly recruits top Swedish researcher in Alzheimer´s

One of Sweden's leading Alzheimer's researchers, Oskar Hansson, has been recruited by pharma giant Eli Lilly and will be moving to the USA.